Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance

Gut Microbes

Volumn 5, Issue 1, 2013, Pages 15-27

  Gerding, Dale N ^a   Johnson, Stuart ^a   Rupnik, Maja ^b   Aktories, Klaus ^c  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Binary toxin; CDT; Clostridium difficile infection; Disease severity; Mechanism; Mortality; PCR ribotyping; Toxinotyping

Indexed keywords

ACTIN; BACTERIAL TOXIN; BINARY TOXIN; BINARY TOXIN A; BINARY TOXIN B; CLINDAMYCIN; FIDAXOMICIN; LIPOPROTEIN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; VANCOMYCIN; ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE, CLOSTRIDIUM; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CHEMICAL STRUCTURE; CLOSTRIDIUM DIFFICILE INFECTION; DEPOLYMERIZATION; DIARRHEA; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; MICROTUBULE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; ANIMAL; CHEMISTRY; CLOSTRIDIUM INFECTIONS; GENETICS; METABOLISM; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

ACTINS; ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIAL PROTEINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS;

EID: 84891773348     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.26854     Document Type: Article

References (118)

1. McDonald LC, Killgore GE, Thompson A, Owens RC Jr., Kazakova SV, Sambol SP, Johnson S, Gerding DN. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41; PMID:16322603; http://dx.doi.org/10.1056/NEJMoa051590
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9; PMID:16322602; http://dx.doi.org/10.1056/NEJMoa051639
3. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47:1162-70; PMID:18808358; http://dx.doi.org/10.1086/592257
4. Rupnik M. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes. FEMS Microbiol Rev 2008; 32:541-55; PMID:18397287; http://dx.doi.org/10.1111/j.1574-6976.2008.00110.x
5. Debast SB, van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 2009; 11:505-11; PMID:19196280; http://dx.doi.org/10.1111/j.1462-2920.2008.01790.x
6. Barbut F, Rupnik M. Editorial commentary: 027, 078, and others: going beyond the numbers (and away from the hypervirulence). Clin Infect Dis 2012; 55:1669-72; PMID:22972865; http://dx.doi.org/10.1093/cid/cis790
7. Aktories K, Bärmann M, Ohishi I, Tsuyama S, Jakobs KH, Habermann E. Botulinum C2 toxin ADP-ribosylates actin. Nature 1986; 322:390-2; PMID:3736664; http://dx.doi.org/10.1038/322390a0
8. Aktories K, Wille M, Just I. Clostridial actin-ADP-ribosylating toxins. Curr Top Microbiol Immunol 1992; 175:97-113; PMID:1628500; http://dx.doi.org/10.1007/978-3-642-76966-5_5
9. Popoff MR, Boquet P. Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem Biophys Res Commun 1988; 152:1361-8; PMID:2897847; http://dx.doi.org/10.1016/S0006-291X(88)80435-2
10. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56:2299-306; PMID:3137166
11. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 1997; 65:1402-7; PMID:9119480
12. Braun M, Herholz C, Straub R, Choisat B, Frey J, Nicolet J, Kuhnert P. Detection of the ADP-ribosyltransferase toxin gene (cdtA) and its activity in Clostridium difficile isolates from Equidae. FEMS Microbiol Lett 2000; 184:29-33; PMID:10689161; http://dx.doi.org/10.1111/j.1574-6968.2000.tb08985.x
13. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000; 186:307-12; PMID:10802189; http://dx.doi.org/10.1111/j.1574-6968.2000.tb09122.x
14. Carter GP, Lyras D, Allen DL, Mackin KE, Howarth PM, O'Connor JR, Rood JI. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 2007; 189:7290-301; PMID:17693517; http://dx.doi.org/10.1128/JB.00731-07
15. Stare BG, Delmée M, Rupnik M. Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains. J Med Microbiol 2007; 56:329-35; PMID:17314362; http://dx.doi.org/10.1099/jmm.0.46931-0
16. Pituch H, Kreft D, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M, van Belkum A. Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea. J Clin Microbiol 2005; 43:472-5; PMID:15635019; http://dx.doi.org/10.1128/JCM.43.1.472-475.2005
17. Bouvet PJ, Popoff MR. Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J Clin Microbiol 2008; 46:3703-13; PMID:18832125; http://dx.doi.org/10.1128/JCM.00866-08
18. Metcalf DS, Weese JS. Binary toxin locus analysis in Clostridium difficile. J Med Microbiol 2011; 60:1137-45; PMID:21459907; http://dx.doi.org/10.1099/jmm.0.028498-0
19. Barth H, Aktories K, Popoff MR, Stiles BG. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. [table.]. Microbiol Mol Biol Rev 2004; 68:373-402; PMID:15353562; http://dx.doi.org/10.1128/MMBR.68.3.373-402.2004
20. Chang SY, Song KP. ADP-ribosylating binary toxin genes of Clostridium difficile strain CCUG 20309. DNA Seq 2001; 12:115-20; PMID:11761709
21. Sundriyal A, Roberts AK, Shone CC, Acharya KR. Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile. J Biol Chem 2009; 284:28713-9; PMID:19692332; http://dx.doi.org/10.1074/jbc.M109.043018
22. Han S, Craig JA, Putnam CD, Carozzi NB, Tainer JA. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol 1999; 6:932-6; PMID:10504727; http://dx.doi.org/10.1038/13300
23. Gülke I, Pfeifer G, Liese J, Fritz M, Hofmann F, Aktories K, Barth H. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun 2001; 69:6004-11; PMID:11553537; http://dx.doi.org/10.1128/IAI.69.10.6004-6011.2001
24. Tsuge H, Nagahama M, Oda M, Iwamoto S, Utsunomiya H, Marquez VE, Katunuma N, Nishizawa M, Sakurai J. Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin. Proc Natl Acad Sci U S A 2008; 105:7399-404; PMID:18490658; http://dx.doi.org/10.1073/pnas.0801215105
25. Young JA, Collier RJ. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 2007; 76:243-65; PMID:17335404; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142728
26. Schleberger C, Hochmann H, Barth H, Aktories K, Schulz GE. Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol 2006; 364:705-15; PMID:17027031; http://dx.doi.org/10.1016/j.jmb.2006.09.002
27. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC. Crystal structure of the anthrax toxin protective antigen. Nature 1997; 385:833-8; PMID:9039918; http://dx.doi.org/10.1038/385833a0
28. Barth H, Blocker D, Behlke J, Bergsma-Schutter W, Brisson A, Benz R, Aktories K. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J Biol Chem 2000; 275:18704-11; PMID:10749859; http://dx.doi.org/10.1074/jbc.M000596200
29. Kintzer AF, Thoren KL, Sterling HJ, Dong KC, Feld GK, Tang II, Zhang TT, Williams ER, Berger JM, Krantz BA. The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol 2009; 392:614-29; PMID:19627991; http://dx.doi.org/10.1016/j.jmb.2009.07.037
30. Blöcker D, Behlke J, Aktories K, Barth H. Cellular uptake of the Clostridium perfringens binary iota-toxin. Infect Immun 2001; 69:2980-7; PMID:11292715; http://dx.doi.org/10.1128/IAI.69.5.2980-2987.2001
31. Nagahama M, Nagayasu K, Kobayashi K, Sakurai J. Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells. Infect Immun 2002; 70:1909-14; PMID:11895954; http://dx.doi.org/10.1128/IAI.70.4.1909-1914.2002
32. Papatheodorou P, Carette JE, Bell GW, Schwan C, Guttenberg G, Brummelkamp TR, Aktories K. Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A 2011; 108:16422-7; PMID:21930894; http://dx.doi.org/10.1073/pnas.1109772108
33. Yen FT, Masson M, Clossais-Besnard N, André P, Grosset JM, Bougueleret L, Dumas JB, Guerassimenko O, Bihain BE. Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem 1999; 274:13390-8; PMID:10224102; http://dx.doi.org/10.1074/jbc.274.19.13390
34. Mesli S, Javorschi S, Bérard AM, Landry M, Priddle H, Kivlichan D, Smith AJ, Yen FT, Bihain BE, Darmon M. Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-/-embryos at 12.5 to 14.5 days of gestation. Eur J Biochem 2004; 271:3103-14; PMID:15265030; http://dx.doi.org/10.1111/j.1432-1033.2004.04223.x
35. Papatheodorou P, Wilczek C, Nölke T, Guttenberg G, Hornuss D, Schwan C, Aktories K. Identification of the cellular receptor of Clostridium spiroforme toxin. Infect Immun 2012; 80:1418-23; PMID:22252869; http://dx.doi.org/10.1128/IAI.06378-11
36. Yen FT, Mann CJ, Guermani LM, Hannouche NF, Hubert N, Hornick CA, Bordeau VN, Agnani G, Bihain BE. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry 1994; 33:1172-80; PMID:7509190; http://dx.doi.org/10.1021/bi00171a017
37. Yen FT, Roitel O, Bonnard L, Notet V, Pratte D, Stenger C, Magueur E, Bihain BE. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J Biol Chem 2008; 283:25650-9; PMID:18644789; http://dx.doi.org/10.1074/jbc.M801027200
38. Mann CJ, Khallou J, Chevreuil O, Troussard AA, Guermani LM, Launay K, Delplanque B, Yen FT, Bihain BE. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Biochemistry 1995; 34:10421-31; PMID:7654696; http://dx.doi.org/10.1021/bi00033a014
39. Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, Furuse M. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 2011; 124:548-55; PMID:21245199; http://dx.doi.org/10.1242/jcs.072058
40. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005; 171:939-45; PMID:16365161; http://dx.doi.org/10.1083/jcb.200510043
41. Higashi T, Tokuda S, Kitajiri S, Masuda S, Nakamura H, Oda Y, Furuse M. Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2--tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. J Cell Sci 2013; 126:966-77; PMID:23239027; http://dx.doi.org/10.1242/jcs.116442
42. Wigelsworth DJ, Ruthel G, Schnell L, Herrlich P, Blonder J, Veenstra TD, Carman RJ, Wilkins TD, Van Nhieu GT, Pauillac S, et al. CD44 Promotes intoxication by the clostridial iota-family toxins. PLoS One 2012; 7:e51356; PMID:23236484; http://dx.doi.org/10.1371/journal.pone.0051356
43. Nagahama M, Sakaguchi Y, Kobayashi K, Ochi S, Sakurai J. Characterization of the enzymatic component of Clostridium perfringens iota-toxin. J Bacteriol 2000; 182:2096-103; PMID:10735850; http://dx.doi.org/10.1128/JB.182.8.2096-2103.2000
44. Nagahama M, Yamaguchi A, Hagiyama T, Ohkubo N, Kobayashi K, Sakurai J. Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts. Infect Immun 2004; 72:3267-75; PMID:15155629; http://dx.doi.org/10.1128/IAI.72.6.3267-3275.2004
45. Hale ML, Marvaud JC, Popoff MR, Stiles BG. Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin. Infect Immun 2004; 72:2186-93; PMID:15039342; http://dx.doi.org/10.1128/IAI.72.4.2186-2193.2004
46. Marvaud JC, Smith T, Hale ML, Popoff MR, Smith LA, Stiles BG. Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib. Infect Immun 2001; 69:2435-41; PMID:11254604; http://dx.doi.org/10.1128/IAI.69.4.2435-2441.2001
47. Nagahama M, Umezaki M, Oda M, Kobayashi K, Tone S, Suda T, Ishidoh K, Sakurai J. Clostridium perfringens iota-toxin b induces rapid cell necrosis. Infect Immun 2011; 79:4353-60; PMID:21911469; http://dx.doi.org/10.1128/IAI.05677-11
48. Nagahama M, Umezaki M, Tashiro R, Oda M, Kobayashi K, Shibutani M, Takagishi T, Ishidoh K, Fukuda M, Sakurai J. Intracellular trafficking of Clostridium perfringens iota-toxin b. Infect Immun 2012; 80:3410-6; PMID:22825447; http://dx.doi.org/10.1128/IAI.00483-12
49. Krantz BA, Trivedi AD, Cunningham K, Christensen KA, Collier RJ. Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin. J Mol Biol 2004; 344:739-56; PMID:15533442; http://dx.doi.org/10.1016/j.jmb.2004.09.067
50. Krantz BA, Finkelstein A, Collier RJ. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient. J Mol Biol 2006; 355:968-79; PMID:16343527; http://dx.doi.org/10.1016/j.jmb.2005.11.030
51. Schmid A, Benz R, Just I, Aktories K. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes. Formation of cation-selective channels and inhibition of channel function by chloroquine. J Biol Chem 1994; 269:16706-11; PMID:7515883
52. Bachmeyer C, Benz R, Barth H, Aktories K, Gilbert M, Popoff MR. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function by chloroquine and related compounds in vitro and intoxification in vivo. FASEB J 2001; 15:1658-60; PMID:11427518
53. Blöcker D, Bachmeyer C, Benz R, Aktories K, Barth H. Channel formation by the binding component of Clostridium botulinum C2 toxin: glutamate 307 of C2II affects channel properties in vitro and pH-dependent C2I translocation in vivo. Biochemistry 2003; 42:5368-77; PMID:12731878; http://dx.doi.org/10.1021/bi034199e
54. Lang AE, Neumeyer T, Sun J, Collier RJ, Benz R, Aktories K. Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxin. Biochemistry 2008; 47:8406-13; PMID:18636745; http://dx.doi.org/10.1021/bi800615g
55. Knapp O, Benz R, Gibert M, Marvaud JC, Popoff MR. Interaction of Clostridium perfringens iota-toxin with lipid bilayer membranes. Demonstration of channel formation by the activated binding component Ib and channel block by the enzyme component Ia. J Biol Chem 2002; 277:6143-52; PMID:11741922; http://dx.doi.org/10.1074/jbc.M103939200
56. Krantz BA, Melnyk RA, Zhang S, Juris SJ, Lacy DB, Wu Z, Finkelstein A, Collier RJ. A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science 2005; 309:777-81; PMID:16051798; http://dx.doi.org/10.1126/science.1113380
57. Haug G, Wilde C, Leemhuis J, Meyer DK, Aktories K, Barth H. Cellular uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin requires unfolding of its dihydrofolate reductase domain. Biochemistry 2003; 42:15284-91; PMID:14690438; http://dx.doi.org/10.1021/bi0354278
58. Haug G, Aktories K, Barth H. The host cell chaperone Hsp90 is necessary for cytotoxic action of the binary iota-like toxins. Infect Immun 2004; 72:3066-8; PMID:15102823; http://dx.doi.org/10.1128/IAI.72.5.3066-3068.2004
59. Haug G, Leemhuis J, Tiemann D, Meyer DK, Aktories K, Barth H. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. J Biol Chem 2003; 278:32266-74; PMID:12805360; http://dx.doi.org/10.1074/jbc.M303980200
60. Kaiser E, Kroll C, Ernst K, Schwan C, Popoff M, Fischer G, Buchner J, Aktories K, Barth H. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. Infect Immun 2011; 79:3913-21; PMID:21768281; http://dx.doi.org/10.1128/IAI.05372-11
61. Kaiser E, Böhm N, Ernst K, Langer S, Schwan C, Aktories K, Popoff M, Fischer G, Barth H. FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells. Cell Microbiol 2012; 14:1193-205; PMID:22420783; http://dx.doi.org/10.1111/j.1462-5822.2012.01788.x
62. Pollard TD, Cooper JA. Actin, a central player in cell shape and movement. Science 2009; 326:1208-12; PMID:19965462; http://dx.doi.org/10.1126/science.1175862
63. Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys 2011; 40:169-86; PMID:21314430; http://dx.doi.org/10.1146/annurev-biophys-042910-155359
64. Lanzetti L. Actin in membrane trafficking. Curr Opin Cell Biol 2007; 19:453-8; PMID:17616384; http://dx.doi.org/10.1016/j.ceb.2007.04.017
65. Disanza A, Steffen A, Hertzog M, Frittoli E, Rottner K, Scita G. Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement. Cell Mol Life Sci 2005; 62:955-70; PMID:15868099; http://dx.doi.org/10.1007/s00018-004-4472-6
66. Vandekerckhove J, Schering B, Bärmann M, Aktories K. Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett 1987; 225:48-52; PMID:2891567; http://dx.doi.org/10.1016/0014-5793(87)81129-8
67. Vandekerckhove J, Schering B, Bärmann M, Aktories K. Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. J Biol Chem 1988; 263:696-700; PMID:3335520
68. Aktories K, Lang AE, Schwan C, Mannherz HG. Actin as target for modification by bacterial protein toxins. FEBS J 2011; 278:4526-43; PMID:21466657; http://dx.doi.org/10.1111/j.1742-4658.2011.08113.x
69. Visschedyk DD, Perieteanu AA, Turgeon ZJ, Fieldhouse RJ, Dawson JF, Merrill AR. Photox, a novel actin-targeting mono-ADP-ribosyltransferase from Photorhabdus luminescens. J Biol Chem 2010; 285:13525-34; PMID:20181945; http://dx.doi.org/10.1074/jbc.M109.077339
70. Braun M, Stuber K, Schlatter Y, Wahli T, Kuhnert P, Frey J. Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida. J Bacteriol 2002; 184:1851-8; PMID:11889090; http://dx.doi.org/10.1128/JB.184.7.1851-1858.2002
71. Hochmann H, Pust S, von Figura G, Aktories K, Barth H. Salmonella enterica SpvB ADP-ribosylates actin at position arginine-177-characterization of the catalytic domain within the SpvB protein and a comparison to binary clostridial actin-ADP-ribosylating toxins. Biochemistry 2006; 45:1271-7; PMID:16430223; http://dx.doi.org/10.1021/bi051810w
72. Wegner A, Aktories K. ADP-ribosylated actin caps the barbed ends of actin filaments. J Biol Chem 1988; 263:13739-42; PMID:2901417
73. Wille M, Just I, Wegner A, Aktories K. ADP-ribosylation of gelsolin-actin complexes by clostridial toxins. J Biol Chem 1992; 267:50-5; PMID:1309748
74. Aktories K, Wegner A. ADP-ribosylation of actin by clostridial toxins. J Cell Biol 1989; 109:1385-7; PMID:2677017; http://dx.doi.org/10.1083/jcb.109.4.1385
75. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt WD, Wehland J, Aktories K. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 2009; 5:e1000626; PMID:19834554; http://dx.doi.org/10.1371/journal.ppat.1000626
76. Lansbergen G, Akhmanova A. Microtubule plus end: a hub of cellular activities. Traffic 2006; 7:499-507; PMID:16643273; http://dx.doi.org/10.1111/j.1600-0854.2006.00400.x
77. Siegrist SE, Doe CQ. Microtubule-induced cortical cell polarity. Genes Dev 2007; 21:483-96; PMID:17344411; http://dx.doi.org/10.1101/gad.1511207
78. Geric B, Johnson S, Gerding DN, Grabnar M, Rupnik M. Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 2003; 41:5227-32; PMID:14605169; http://dx.doi.org/10.1128/JCM.41.11.5227-5232.2003
79. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56:2299-306; PMID:3137166
80. Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003; 41:1118-25; PMID:12624039; http://dx.doi.org/10.1128/JCM.41.3.1118-1125.2003
81. Gonçalves C, Decré D, Barbut F, Burghoffer B, Petit JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 2004; 42:1933-9; PMID:15131151; http://dx.doi.org/10.1128/JCM.42.5.1933-1939.2004
82. Terhes G, Urbán E, Sóki J, Hamid KA, Nagy E. Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 2004; 42:4316-8; PMID:15365032; http://dx.doi.org/10.1128/JCM.42.9.4316-4318.2004
83. Pituch H, Rupnik M, Obuch-Woszczatynski P, Grubesic A, Meisel-Mikołajczyk F, Luczak M. Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland. J Med Microbiol 2005; 54:143-7; PMID:15673507; http://dx.doi.org/10.1099/jmm.0.45799-0
84. Alonso R, Martín A, Peláez T, Marín M, Rodríguez-Creixéms M, Bouza E. Toxigenic status of Clostridium difficile in a large Spanish teaching hospital. J Med Microbiol 2005; 54:159-62; PMID:15673510; http://dx.doi.org/10.1099/jmm.0.45809-0
85. Geric B, Rupnik M, Gerding DN, Grabnar M, Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004; 53:887-94; PMID:15314196; http://dx.doi.org/10.1099/jmm.0.45610-0
86. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-72; PMID:11882758; http://dx.doi.org/10.1097/00000658-200203000-00008
87. Black SR, Weaver KN, Jones RC, Ritger KA, Petrella LA, Sambol SP, Vernon M, Burton S, Garcia-Houchins S, Weber SG, et al. Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals. Infect Control Hosp Epidemiol 2011; 32:897-902; PMID:21828970; http://dx.doi.org/10.1086/661283
88. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12(Suppl 6):2-18; PMID:16965399; http://dx.doi.org/10.1111/j.1469-0691.2006.01580.x
89. Spigaglia P, Mastrantonio P. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 2004; 53:1129-36; PMID:15496392; http://dx.doi.org/10.1099/jmm.0.45682-0
90. Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I; European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13:1048-57; PMID:17850341; http://dx.doi.org/10.1111/j.1469-0691.2007.01824.x
91. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377:63-73; PMID:21084111; http://dx.doi.org/10.1016/S0140-6736(10)61266-4
92. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect 2007; 13:457-9; PMID:17331126; http://dx.doi.org/10.1111/j.1469-0691.2007.01687.x
93. Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 2007; 45:1963-4; PMID:17428945; http://dx.doi.org/10.1128/JCM.00224-07
94. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, McDonald LC, Limbago BM. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 2008; 14:1039-45; PMID:18598622; http://dx.doi.org/10.3201/eid1407.071641
95. Rodriguez-Palacios A, Staempfli HR, Duffield T, Weese JS. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 2007; 13:485-7; PMID:17552108; http://dx.doi.org/10.3201/eid1303.060988
96. Songer JG, Trinh HT, Dial SM, Brazier JS, Glock RD. Equine colitis X associated with infection by Clostridium difficile NAP1/027. J Vet Diagn Invest 2009; 21:377-80; PMID:19407094; http://dx.doi.org/10.1177/104063870902100314
97. Hensgens MP, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, Lipman LJ, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 2012; 18:635-45; PMID:22536816; http://dx.doi.org/10.1111/j.1469-0691.2012.03853.x
98. Gould LH, Limbago B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis 2010; 51:577-82; PMID:20642351; http://dx.doi.org/10.1086/655692
99. Barbut F, Decré D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005; 54:181-5; PMID:15673514; http://dx.doi.org/10.1099/jmm.0.45804-0
100. Walk ST, Micic D, Jain R, Lo ES, Trivedi I, Liu EW, Almassalha LM, Ewing SA, Ring C, Galecki AT, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012; 55:1661-8; PMID:22972866; http://dx.doi.org/10.1093/cid/cis786
101. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 2009; 7:868-73, e2; PMID:19465153; http://dx.doi.org/10.1016/j.cgh.2009.05.018
102. Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, Gerding DN, Llewelyn MJ. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010; 50:e77-81; PMID:20450417; http://dx.doi.org/10.1086/653012
103. Morgan OW, Rodrigues B, Elston T, Verlander NQ, Brown DF, Brazier J, Reacher M. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 2008; 3:e1812; PMID:18350149; http://dx.doi.org/10.1371/journal.pone.0001812
104. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS, Babakhani F, Johnson S, Gerding DN. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55:351-7; PMID:22523271; http://dx.doi.org/10.1093/cid/cis430
105. Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, Gardam M, McGeer A, Hutchinson J, Moore D, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50:194-201; PMID:20025526; http://dx.doi.org/10.1086/649213
106. Goldenberg SD, French GL. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 2011; 62:355-62; PMID:21396957; http://dx.doi.org/10.1016/j.jinf.2011.03.001
107. Bacci S, Mølbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 2011; 17:976-82; PMID:21749757
108. Barbut F, Gariazzo B, Bonné L, Lalande V, Burghoffer B, Luiuz R, Petit JC. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007; 28:131-9; PMID:17265393; http://dx.doi.org/10.1086/511794
109. Stewart DB, Berg A, Hegarty J. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J Gastrointest Surg 2013; 17:118-24, discussion 124-5; PMID:23086451; http://dx.doi.org/10.1007/s11605-012-2056-6
110. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, Oakley S, O'Connor L, Finney J, Vaughan A, et al.; Infections in Oxfordshire Research Database. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 2013; 56:1589-600; PMID:23463640; http://dx.doi.org/10.1093/cid/cit127
111. Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, Lyerly DM, Gerding DN, Johnson S. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006; 193:1143-50; PMID:16544255; http://dx.doi.org/10.1086/501368
112. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP. The importance of toxin A, toxin B and CDT in virulence of an epidemic Clostridium difficile strain. [Epub ahead of print]. J Infect Dis 2013; PMID:23935202; http://dx.doi.org/10.1093/infdis/jit426
113. Carman RJ, Stevens AL, Lyerly MW, Hiltonsmith MF, Stiles BG, Wilkins TD. Clostridium difficile binary toxin (CDT) and diarrhea. Anaerobe 2011; 17:161-5; PMID:21376825; http://dx.doi.org/10.1016/j.anaerobe.2011.02.005
114. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr., Leney M, Sloan S, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010; 362:197-205; PMID:20089970; http://dx.doi.org/10.1056/NEJMoa0907635
115. Babcock GJ, Broering TJ, Hernandez HJ, Mandell RB, Donahue K, Boatright N, Stack AM, Lowy I, Graziano R, Molrine D, et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters. Infect Immun 2006; 74:6339-47; PMID:16966409; http://dx.doi.org/10.1128/IAI.00982-06
116. Barth H, Blöcker D, Aktories K. The uptake machinery of clostridial actin ADP-ribosylating toxins-a cell delivery system for fusion proteins and polypeptide drugs. Naunyn Schmiedebergs Arch Pharmacol 2002; 366:501-12; PMID:12444490; http://dx.doi.org/10.1007/s00210-002-0626-y
117. Barth H, Stiles BG. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells. Curr Med Chem 2008; 15:459-69; PMID:18289001; http://dx.doi.org/10.2174/092986708783503195
118. Elliott B, Squire MM, Thean S, Chang BJ, Brazier JS, Rupnik M, Riley TV. New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J Med Microbiol 2011; 60:1108-11; PMID:21393460; http://dx.doi.org/10.1099/jmm.0.031062-0